» Articles » PMID: 33298026

The Global, Regional, and National Burden of Pancreatitis in 195 Countries and Territories, 1990-2017: a Systematic Analysis for the Global Burden of Disease Study 2017

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2020 Dec 10
PMID 33298026
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatitis is a critical public health problem, and the burden of pancreatitis is increasing. We report the rates and trends of the prevalence, incidence, and years lived with disability (YLDs) for pancreatitis at the global, regional, and national levels in 195 countries and territories from 1990 to 2017, stratified by sex, age, and sociodemographic index (SDI).

Methods: Data on pancreatitis were available from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. Numbers and age-standardized prevalence, incidence, and YLDs' rates per 100,000 population were estimated through a systematic analysis of modeled data from the 2017 GBD study. Both acute and chronic pancreatitis are being modeled separately in the GBD 2017; however, our data show acute and chronic pancreatitis together. Estimates were reported with uncertainty intervals (UIs).

Results: Globally, in 2017, the age-standardized rates were 76.2 (95% UIs 68.9 to 83.4), 20.6 (19.2 to 22.1), and 4.5 (2.3 to 7.6) per 100,000 population for the point prevalence, incidence, and YLDs, respectively. From 1990 to 2017, the percent changes in the age-standardized prevalence and YLDs rates increased, whereas the age-standardized incidence rate decreased. The global prevalence increased with age up to 60-64 years and 44-49 years in females and males, respectively, and then decreased, with no significant difference between females and males. The global prevalence rate increased with age, peaking in the 95+ age group, with no difference between sexes. Generally, positive correlation between age-standardized YLDs and SDIs at the regional and national levels was observed. Slovakia (297.7 [273.4 to 325.3]), Belgium (274.3 [242.6 to 306.5]), and Poland (266.7 [248.2 to 284.4]) had the highest age-standardized prevalence rates in 2017. Taiwan (Province of China) (104.2% [94.8 to 115.2%]), Maldives (72.4% [66.5 to 79.2%]), and Iceland (64.8% [57.2 to 72.9%]) had the largest increases in age-standardized prevalence rates from 1990 to 2017.

Conclusions: Pancreatitis is a major public health issue worldwide. The age-standardized prevalence and YLDs rates increased, but the age-standardized incidence rate decreased from 1990 to 2017. Improving the quality of pancreatitis health data in all regions and countries is strongly recommended for better monitoring the burden of pancreatitis.

Citing Articles

Acute Pancreatitis in Pregnancy and Puerperium: Assessing Maternal and Fetal Impact, Etiologies, and Clinical Outcomes at a Tertiary Care Hospital in Pakistan.

Anees F, Khan R, Naz S, Wadani Z Cureus. 2025; 16(12):e76393.

PMID: 39867050 PMC: 11762428. DOI: 10.7759/cureus.76393.


Mitochondrial uncoupling protein 2: a central player in pancreatic disease pathophysiology.

Wang K, Zhang L, Deng B, Zhao K, Chen C, Wang W Mol Med. 2024; 30(1):259.

PMID: 39707176 PMC: 11660649. DOI: 10.1186/s10020-024-01027-y.


Global, regional, and national pancreatitis burden and health inequality of pancreatitis from 1990 to 2019 with a prediction from 2020 to 2034.

Wen Y, Luo Y, Huang Y, Zhang Z, Xiong L, Wang Y BMC Public Health. 2024; 24(1):3329.

PMID: 39614245 PMC: 11606095. DOI: 10.1186/s12889-024-20796-z.


Natural Compounds for the Treatment of Acute Pancreatitis: Novel Anti-Inflammatory Therapies.

Jiang W, Li X, Zhang Y, Zhou W Biomolecules. 2024; 14(9).

PMID: 39334867 PMC: 11430608. DOI: 10.3390/biom14091101.


Effect of probiotics combined with Ulinastatin and Somatostatin in the treatment of severe acute pancreatitis.

Dou H, Kan Y, Xu Z, Wang Z, Zheng C Pak J Med Sci. 2024; 40(8):1729-1734.

PMID: 39281215 PMC: 11395351. DOI: 10.12669/pjms.40.8.9744.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

3.
Hirota M, Shimosegawa T, Masamune A, Kikuta K, Kume K, Hamada S . The seventh nationwide epidemiological survey for chronic pancreatitis in Japan: clinical significance of smoking habit in Japanese patients. Pancreatology. 2014; 14(6):490-6. DOI: 10.1016/j.pan.2014.08.008. View

4.
Morinville V, Barmada M, Lowe M . Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible?. Pancreas. 2009; 39(1):5-8. DOI: 10.1097/MPA.0b013e3181baac47. View

5.
. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View